Intravesical BCG vs GEMDOCE in NMIBC

NCT05538663 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

870

Enrollment

NETWORK

Sponsor class

Conditions

Non-muscle-invasive Bladder Cancer

Interventions

DRUG: Gemcitabine
DRUG: Docetaxel
DRUG: Bacillus Calmette Guerin

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]